Max-001
-
King of Prussia-based Maxona Pharmaceuticals Raises Millions in Private Sale to Advance Its Medication Portfolio
King of Prussia-based Maxona Pharmaceuticals has raised $5.56 million in a private sale to advance its non-opioid and non-steroidal pain…










![ForAll_Digital-Ad_Malaika_376x628[44]](https://montco.today/wp-content/uploads/sites/2/2022/06/ForAll_Digital-Ad_Malaika_376x62844.jpg)




















